Clinical and biological characteristics of MGUS and SMM patients according to the type of immunoglobulin
Characteristics . | MGUS(n = 407) . | SMM(n = 93) . |
---|---|---|
Sex, male/female, no. | 205/202 | 46/47 |
Age, y (range) | 71 (26-95) | 69 (39-88) |
Serum MC, mg/dL (range) | 1.60 (0.3-3.0) | 2.37 (0.8-6.5) |
Immunoparesis, no. (%) | 90 (25%) | 47(52%) |
BM PC by morphology, % (range) | 4 (1-10) | 14 (4-55) |
BM PC by FC, % (range) | 1.0 (0.1-37) | 2.9 (0. 9-27) |
Abnormal PC, % (range) | 73 (0-100) | 97 (17-100) |
Patients with greater than 95% aPC, % (%) | 73 (18) | 56 (60) |
Presence of BJ proteinuria, no. (%) | 40 (17) | 14 (22) |
Aneuploidity, no. (%) | 229 (58) | 62 (67) |
Progression, no. (%) | 33 (8) | 40 (43) |
Characteristics . | MGUS(n = 407) . | SMM(n = 93) . |
---|---|---|
Sex, male/female, no. | 205/202 | 46/47 |
Age, y (range) | 71 (26-95) | 69 (39-88) |
Serum MC, mg/dL (range) | 1.60 (0.3-3.0) | 2.37 (0.8-6.5) |
Immunoparesis, no. (%) | 90 (25%) | 47(52%) |
BM PC by morphology, % (range) | 4 (1-10) | 14 (4-55) |
BM PC by FC, % (range) | 1.0 (0.1-37) | 2.9 (0. 9-27) |
Abnormal PC, % (range) | 73 (0-100) | 97 (17-100) |
Patients with greater than 95% aPC, % (%) | 73 (18) | 56 (60) |
Presence of BJ proteinuria, no. (%) | 40 (17) | 14 (22) |
Aneuploidity, no. (%) | 229 (58) | 62 (67) |
Progression, no. (%) | 33 (8) | 40 (43) |